TransMolecular
Latest round
- Series C
Last raised
- Mar 2004
Total raised
- $42M
Investors
- 14
About TransMolecular
TransMolecular is a biotechnology company based in Massachusetts, US. It focuses on developing and commercializing novel and proprietary drugs to diagnose and treat human cancers having inadequate pharmaceutical alternatives.
Who invested in TransMolecular
14 investors across 3 rounds
See all investors in TransMolecular
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TransMolecular
Who invested in TransMolecular?
TransMolecular has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TransMolecular raised?
TransMolecular has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did TransMolecular last raise money?
TransMolecular's most recent round on record is a Series C, in Mar 2004.
What does TransMolecular do?
TransMolecular is a biotechnology company based in Massachusetts, US.
Where is TransMolecular headquartered?
TransMolecular is headquartered in Cambridge, US.
Which VCs invest in companies like TransMolecular?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at TransMolecular's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like TransMolecular? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.